(NASDAQ: PYPD) Polypid's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 13.28%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.17%.
Polypid's earnings in 2025 is -$29,022,000.On average, 1 Wall Street analyst forecast PYPD's earnings for 2025 to be -$19,056,990, with the lowest PYPD earnings forecast at -$19,056,990, and the highest PYPD earnings forecast at -$19,056,990.
In 2026, PYPD is forecast to generate -$11,821,449 in earnings, with the lowest earnings forecast at -$11,821,449 and the highest earnings forecast at -$11,821,449.